With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To help navigate the new legislative ...
There are a number of court cases playing out across the country that could affect the options state and territorial health officials have to limit the spread of disease and promote health and well-being.
Adopting a public health approach to substance use by implementing harm reduction policies across all levels of government can help communities address the overdose crisis. This post analyzes e
In 2023 legislative sessions, states considered measures to improve access to care for pregnant people experiencing substance use disorder, increase provider knowledge of screening and treatment practices, coordinate care for conditions ...
Across the nation, public health agencies have mounted herculean efforts to stem the COVID-19 pandemic while addressing a pre-existing HIV epidemic and an opioid crisis that is serving as a source for many new HIV outbreaks. Tackling these ...
Perinatal substance use is a serious public health issue, resulting in detrimental and even life-threatening fetal outcomes, and it continues to grow.
The COVID-19 pandemic has negatively impacted youth mental health, particularly as a result of school closures, social isolation, family economic hardship, fear of family loss or illness, and reduced access to healthcare. However, states ...
This ASTHOReport builds on a 2020 document and reflects the current state and federal landscape regarding disruptions, shares updated recommendations on strategies states might use to mitigate risks to patients affected by a disruption, ...
In the November 2020 election, voters in several states cast their ballots on proposals related to the use of legal and illicit drugs. These ballot proposals influence key public health issues such as tobacco control, substance use ...
Overdose Prevention Policy Considerations: A Policy Playbook for State and Territorial Health Officials and Agencies overdose prevention, drug checking equipment, syringe services, health equity, reducing stigma, discriminatory policies, ...
This page features ASTHO’s legal mapping work to plot the legal landscape for public health priorities.
Interest is using psilocybins to treat some disorders has reemerged. Some states are taking steps to put that interest into practice.
Neonatal Abstinence Syndrome (NAS) has become more prevalent in the United States, with the hospitalization rate increasing from 2.9 to 7.3 hospitalizations per 1,000 newborn births between 2009 and 2017. NAS occurs in newborns who ...
States have begun to expand their focus when developing new approaches to improve surveillance, promote harm reduction, create linkages to care, and educate providers on opioid overdose reduction.
This brief outlines key considerations for state health departments to keep in mind as they create financing, data, and policy partnerships with behavioral health stakeholders.
ASTHO interview with Elizabeth Harvey, PhD, MPH, a CDC Senior Maternal and Child Health Epidemiology Program assignee to the Tennessee Department of Health. Harvey shares her thoughts on the progress Tennessee has made on opioid use ...
State and territorial health agencies continue to be challenged by the opioid epidemic, which has been exacerbated by the COVID-19 pandemic. Addressing the opioid crisis requires a robust public health response, which could be helped by ...
The opioid crisis continues to claim the lives of thousands across the United States and has cost the economy billions in health care, mortality, and criminal justice costs. In 2018, it’s estimated that 67,367 people died of overdose, with ...
State and local jurisdictions are developing Ending the HOV Epidemic plans. The EHE initiative has largely focused on four key strategies: Diagnose, Treat, Prevent, and Respond to potential outbreaks. The EHE initiative set a goal to ...